GL1X · GenesisL1 explorer

Research workbench

Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of herpes simplex virus type 1 thymidine kinase interacting with (north)-methanocarba-thymidine

Analyse Kinetics and crystal structure of the wild-type and the engineered Y101F mutant… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1E2L
Type
protein
Length
614 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thymidine kinase
EC
2.7.1.21
UniProt
P03176
Ligands
TMC, SO4
Pockets
9 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThymidine kinase (EC 2.7.1.21)protein30458% helix, 13% strandP03176
BThymidine kinase (EC 2.7.1.21)protein31057% helix, 13% strandP03176

Ligands and binding sites

  • TMC · 1-[4-hydroxy-5-(hydroxymethyl)bicyclo[3.1.0]hex-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11250.800.9723TMC
22390.600.8031SO4, TMC
31720.520.7931empty
4950.430.7922empty
51090.430.7820empty

Interfaces

1 interface between chains.

  • A–B · 1728 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 1E2L · Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.